InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by OH ANDREW M.. Director active across 1 company, notably Syros Pharmaceuticals, Inc.. Cumulatively, 3 reports have been published. History available since 16 September 2022. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations